XHKG
0609
Market cap122mUSD
Oct 08, Last price
1.09HKD
1D
6.86%
1Q
3.81%
Jan 2017
-44.67%
IPO
71.65%
Name
Tiande Chemical Holdings Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
As an investment holding company, Tiande Chemical Holdings Limited focuses on the research, development, production, and global distribution of specialized chemical compounds. The company's operational footprint spans numerous international markets, including the People's Republic of China, India, the United States, Taiwan, and the United Kingdom. Its extensive range of primary chemical offerings features substances such as sodium cyanide, cyanoacetic acid and its derivatives, malonates, diethyl ethoxymethylenemalonate, EDTA acids and their salts, mono chloroacetic acid and related compounds, ethanol, tert-butanol, and cyanoacrylate monomers, along with various associated by-products. Beyond chemicals, Tiande also engages in the innovation, manufacturing, and commercialization of medical devices, as well as the production and sale of adhesive solutions. These diverse products are crucial for the synthesis of pharmaceuticals, pesticides, bonding agents, sealants, flavorings, and aromatic substances. Established in 1997, the company is based in Weifang, PRC, and functions as a subsidiary of Cheerhill Group Limited.
Key people
Xiaohua Chen
General Manager, Executive Director · since 2021
Aobo Dou
Executive Director · since 2026
Yang Liu
Executive Chairman of the Board · since 2018
Zijiang Wang
Executive Director · since 2015
Wai Chun Lau
Company Secretary
Kam Wan Leung
Independent Non-Executive Director · since 2007
Chenguang Liu
Independent Non-Executive Director · since 2006
Honghong Shan
Independent Non-Executive Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||